Press Releases Year None202220212020201920182017201620152014201320122011201020092008 May 23, 2022 Concert Pharmaceuticals Reports Positive Topline Results for First CTP-543 Phase 3 Clinical Trial in Alopecia Areata May 5, 2022 Concert Pharmaceuticals Reports First Quarter 2022 Financial Results Apr 28, 2022 Concert Pharmaceuticals to Report First Quarter 2022 Results on May 5, 2022 Mar 3, 2022 Concert Pharmaceuticals Reports 2021 Financial Results and Provides Company Update Feb 24, 2022 Concert Pharmaceuticals to Report Fourth Quarter 2021 Results on March 3, 2022 Jan 4, 2022 Concert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata Jan 3, 2022 Concert Pharmaceuticals to Present at H.C. Wainwright BIOCONNECT Virtual Conference
May 23, 2022 Concert Pharmaceuticals Reports Positive Topline Results for First CTP-543 Phase 3 Clinical Trial in Alopecia Areata
Jan 4, 2022 Concert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata
